FORMULARY DECISION
Abatacept : Orencia
TA195 (SMC 400/07) : In combination with methotrexate, for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have had an insufficient response or intolerance to oth...
Search Results
All Content Formulary Only Other ContentWe have found 6 results when searching "Abatacept"
FORMULARY DECISION
Abatacept : Orencia
TA373 (SMC 618/10) : In combination with methotrexate, abatacept is indicated for the treatment of moderate to severe active polyarticular juvenile idiopathic arthritis (JIA) in paediatric patients 6 ...
FORMULARY DECISION
Abatacept : Orencia
TA375 (SMC 719/11) : In combination with methotrexate, for the treatment of moderate to severe active rheumatoid arthritis in adult patients who responded inadequately to previous therapy with one or ...
FORMULARY DECISION
Abatacept : Orencia
TA375 (SMC 888/13) : In combination with methotrexate, for the treatment of moderate to severe active rheumatoid arthritis in adult patients who responded inadequately to previous therapy with one or ...
FORMULARY DECISION
Abatacept : Orencia
1230/17 : Treatment of highly active and progressive disease in adult patients with rheumatoid arthritis not previously treated with methotrexate.
FORMULARY DECISION
Abatacept : Orencia
1287/17 : Alone or in combination with methotrexate for the treatment of active psoriatic arthritis in adult patients when the response to previous disease-modifying anti-rheumatic drug (DMARD) therap...